|
rs6280
|
|
|
0.100 |
GeneticVariation |
BEFREE |
The meta-analysis comprising 1291 East Asian subjects also showed no association between the polymorphism and TD; the Mantel-Haenszel pooled OR for TD among carriers of the DRD3 Ser9Gly of the eight Asian studies was 0.94 (95% CI: 0.78-1.12).
|
22172931 |
2012 |
|
rs6280
|
|
|
0.100 |
GeneticVariation |
BEFREE |
We conclude that there is no or little association between DRD3 rs6280 polymorphisms and prevalence of TD.
|
19358223 |
2010 |
|
rs6280
|
|
|
0.100 |
GeneticVariation |
BEFREE |
This study investigated the possible relationship between TD and the polymorphisms Ser9Gly (DRD3), 102T>C (HTR2A), -1438G>A(HTR2A) and Cys23Ser (HTR2C) in African-Caribbean inpatients.
|
18562401 |
2009 |
|
rs6280
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Thus, a number of studies have focused on the association of dopamine system gene polymorphisms and TD, with the most consistent findings being an association between TD and the Ser9Gly polymorphism of the DRD3 gene and the TaqIA site 3' of the DRD2 gene.
|
19238168 |
2009 |
|
rs6280
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Search for these determinants has led to a few consensus associations of CYP2D6 *10, CYP1A2*1F, DRD2 Taq1A (rs1800497), DRD3 Ser9Gly (rs6280) and MnSOD Ala9Val (rs4880) variants with TD.
|
18781856 |
2008 |
|
rs6280
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: a meta analysis.
|
16513329 |
2006 |
|
rs6280
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Two gene variants appeared to be significant after adding them to the clinical regression models: (1) Ser9Gly DRD3 polymorphism was associated with severe TD (odds ratio for patients with 1 mutant allele when compared with individuals with 2 wild types was 2.5, 95% confidence interval 1.1-5.6, whereas the odds ratio for patients with 2 mutant alleles when compared with individuals with 1 mutant was 2.8, 95% confidence interval 1.0-7.4), and (2) GSTM1 absence was associated with TD (odds ratio 1.7, 95% confidence interval 1.2-2.4) particularly in white women.
|
16160620 |
2005 |
|
rs6280
|
|
|
0.100 |
GeneticVariation |
BEFREE |
In this study, we examined the association between the DRD3 ser9gly and BDNF val66met genetic polymorphisms and TD occurrence in 216 schizophrenic patients (TD/non-TD = 102/114).
|
15626824 |
2004 |
|
rs6280
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Chinese Han patients with schizophrenia were assessed for abnormal involuntary movements, and subgroups of 42 patients with persistent tardive dyskinesia and 59 consistently without dyskinesias were assessed for the DRD3 ser9gly and the MnSOD ala-9val polymorphisms.
|
12960753 |
2003 |
|
rs6280
|
|
|
0.100 |
GeneticVariation |
BEFREE |
We investigate the association of the polymorphism of the Ser311Cys and Ser9Gly of the dopamine D2 (DRD2) and D3 receptor (DRD3) genes respectively with TD in Chinese patients with schizophrenia.
|
12497614 |
2003 |
|
rs6280
|
|
|
0.100 |
GeneticVariation |
BEFREE |
However, there was no significant allelic association of the Ser9Gly allele with TD (chi2 = 0.288, d.f.
|
12109967 |
2002 |
|
rs6280
|
|
|
0.100 |
GeneticVariation |
BEFREE |
These findings support a small but significant contribution of the DRD3 ser9gly polymorphism to TD susceptibility that is demonstrable over and above population effects and the effect of age and gender on the phenotype.
|
12062911 |
2002 |
|
rs6280
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients.
|
11490179 |
2001 |
|
rs6280
|
|
|
0.100 |
GeneticVariation |
BEFREE |
The dopamine D3 receptor gene (DRD3) ser9gly polymorphism has been previously associated with susceptibility to TD.
|
11140333 |
2000 |
|
rs6280
|
|
|
0.100 |
GeneticVariation |
BEFREE |
We found a high frequency (22-24%) of homozygosity for the Ser9Gly variant (allele 2) of the DRD3 gene among subjects with TD in both a cross-sectional and a longitudinal evaluation, as compared with the relative under-representation (4-6%) of this genotype in patients with no or fluctuating TD.
|
9106238 |
1997 |